ERBB2 and breast cancer: A single molecule-based strategy was developed for the subcellular detection and absolute quantification of endogenously expressed EGFR and HER2 ρR, their respective ratio, and their dimerization behavior, including a quantification of the heterogeneity of these receptor features in breast cancer cells.